hosting two members from the Mechano·Control network. On the one hand, Dimitri
Kaurin, PhD student from Marino Arroyo group at Universitat Politècnica de
Catalunya (UPC) that will be staying at IBEC for at least one year and on the
other hand, Amy Beedle, postdoc from Sergi Garcia-Manyes at Kings College
Dimitri Kaurin started his stay at Pere Roca-Cusachs’ laboratory in December 2018 and it is planned to be for at least a year. One of the objectives of Dimitri’s stay is to work on a protocol to study cell-cell adhesion using a controlled system based on lipid bilayers of controlled viscosity. “Using AFM technique, we expect to access some information about cell-cell adhesion under force” says Dimitri. In the context of this research he will also visit Manuel Salmeron laboratory in Glasgow University this march to learn some techniques about functionalizing lipid bilayers with cadherins.
On the other hand, Amy Beedle arrived this past January to Pere Roca-Cusachs’ laboratory. In the Garcia-Manyes lab Amy was looking at how mechanical forces can trigger conformational changes in individual proteins. Here at IBEC, she wants to incorporate the results at the single molecule level with the cellular level, to try to understand how individual bonds and proteins can contribute to cellular mechanosensing. “My aim is to expand my expertise in single molecule force spectroscopy to a larger cellular context” adds Amy.
This is the first time that both UPC and KCL teams meet with IBEC to share skills and ideas within the project’s framework.
EBSA association grants this prize every two years. The last winner of the prize was Philipp Kukura from the University of Oxford in the UK in 2017. The prize recognises an investigator across Europe who has defended his thesis 12 years ago or less and awards him with 2000€ and a medal as well as be expected to contribute an article to the European Biophysics Journal. The decision of the winning researcher is made by the Executive Committee based on scientific excellence, leadership and creativity.
The European Biophysical Societies Association was formed in 1984 as a non-profit making organisation, with the objectives “to advance and disseminate knowledge of the principles, recent developments and applications of biophysics, and to foster the exchange of scientific information among European biophysicists and biophysicists in general”. It is composed of the Biophysical Societies in the European area and is managed by an Executive Committee. EBSA is associated with the international organizations International Union for Pure and Applied Biophysics (IUPAB) and Initiative for Science in Europe (ISE) and owns the European Biophysics Journal.
consortium, led by several research institutions across Europe, is launching a
Summer School that will be taking place between 17-20 of September 2019 at the
Eco Resort in La Cerdanya. The aim of the summer school is to provide training
on mechanobiology, and specifically its application to breast cancer.
This school will include lectures as well as practical workshops in different
techniques and disciplines, ranging from modelling to biomechanics to cancer
There will be scientific sessions in the morning, mixing 6
keynote speakers with 18 short talks selected from abstract submissions by
junior scientists attending the school. In the afternoon, there will be 2-3-hour
practical workshops, given by scientists from the MECHANO·CONTROL consortium.
The course will also include leisure activities.
to the Summer School is open to all students, post-docs, and professionals
interested, although priority will be given to junior scientists (up to
will be launching the Mechanobiology of Cancer Summer School 2019 website,
where you will find more information about the activities that will be held
during the summer school, information on how to register, and the deadlines
both for the registration and abstract submission.
confirmed speakers who will attend the summer school are:
Marija Plodinec (University Hospital Basel)
Andrew Ewald (Johns Hopkins University School of
Peter Friedl (Radboud University Nijmegen)
Guillaume Salbreux (Francis Crick Institute)
Christina Scheel (Institute of Stem Cell Research,
Helmholtz Center Munich)
Buzz Baum (Medical Research Council
Laboratory for Molecular Cell Biology at UCL)
Also, all MECHANO·CONTROL consortium members will be attending the summer school and will be giving some of the workshops: Aránzazu del Campo (Leibniz-Institut für Neue Materialien, INM), Sergi Garcia-Manyes (King’s College London, KCL), Pere Roca-Cusachs and Xavier Trepat (Institute for Bioengineering of Catalonia, IBEC), Patrick Derksen and Johan de Rooij (University Medical Center Utrecht, UMCU), Marino Arroyo (Universitat Politècnica de Catalunya, UPC) and the companies NovioCell and Mind the Byte.
list of workshop topics:
of tuneable gels
TheMECHANO·CONTROL project is focused on the mechanical control of biological function.Mechanical forces transmitted through specific molecular bonds drive biological function, and their understanding and control holds an uncharted potential in oncology, regenerative medicine and biomaterial design.
MECHANO·CONTROL proposes to address
this challenge by building an interdisciplinary research community with the aim
of understanding and controlling cellular mechanics from the molecular to the
organism scale. At all stages and scales of the project, it will integrate
experimental data with multi-scale computational modelling to establish the
rules driving biological response to mechanics and adhesion. With this
approach, it aims to explore novel therapeutic approaches beyond the current
paradigm in breast cancer treatment. If the partners can understand cancer
biomechanics from the single molecule to the whole organ scale, they’ll be able
to control mechanical forces to restore healthy cell behaviour and inhibit
Beyond breast cancer, the general principles targeted with this technology will have high applicability in oncology, regenerative medicine, biomaterials and many other biological processes and diseases.
MECHANO·CONTROL is a project funded
by the European Commission, within the Future and Emerging Technologies (FET)
A review article by Antoine A. Khalil and Johan de Rooij from UMC Utrecht have appeared in the Experimental Cell Research section of Elsevier
Collective invasion drives the spread of multicellular cancer groups, into the normal tissue surrounding several epithelial tumors. Collective invasion recapitulates various aspects of the multicellular organization and collective migration that take place during normal development and repair. Collective migration starts with the specification of leader cells in which a polarized, migratory phenotype is established.
Leader cells initiate and organize the migration of follower cells, to allow the group of cells to move as a cohesive and polarized unit. Leader-follower specification is essential for coordinated and directional collective movement. Forces exerted by cohesive cells represent key signals that dictate multicellular coordination and directionality. Physical forces originate from the contraction of the actomyosin cytoskeleton, which is linked between cells via cadherin-based cell-cell junctions.
The cadherin complex senses and transduces fluctuations in forces into biochemical signals that regulate processes like cell proliferation, motility and polarity. With cadherin junctions being maintained in most collective movements the cadherin complex is ideally positioned to integrate mechanical information into the organization of collective cell migration. Here we discuss the potential roles of cadherin mechanotransduction in the diverse aspects of leader versus follower cell specification during collective migration and neoplastic invasion.
The biotechnology company Iproteos, IBEC and the Vall d’Hebron Research Institute (VHIR) are set to develop an innovative treatment to slow down, stop and even reverse the growth of solid tumors, which represent more than 90% of cancer cases.
It’s a family of peptidomimetic drugs based on a totally new anti-tumor action mechanism, the result of several years of research by Pere Roca-Cusachs’ group at IBEC.
An opinion piece by IBEC group leader Xavier Trepat has appeared in the News and Views section of the current issue of Nature, which is devoted to ‘Bottom-up biology’.
In his piece ‘Bottom does not explain top’, Xavier argues that understanding how complex biological structures – or even entire cells – are built can only provide a certain amount of insight into how biological systems function at higher levels of organization. There are many variables such as density, or even pathologies suffered by the subject, that affect cell behavior at the mesoscale – that is, at the longer, more ‘system-level’ scale than that of the individual components of an organism. Cells in a group, for example, can sense or respond to external stimuli that an individual cell cannot identify.
Mechano·Control is holding its third consortium meeting today at University Medical Center Utrecht.
Representatives from all seven partners – the UPC and Mind the Byte S.L. in Spain, UMC Utrecht and Noviocell B.V in the Netherlands, Germany’s Leibniz-Institut, and King’s College London – have gathered in the Netherlands for the meeting, which will present and discuss the state of the work packages and results so far.
During the meeting, issues related to the dissemination and exploitation of the project will also be reviewed.
One of the most enviable features of superheroes is their ability to stretch their bodies beyond imaginable limits. In a study published in Nature, scientists have discovered that our cells can do just that.
With every beat of the heart and every breath into the lungs, cells in our body are routinely subjected to extreme stretching. This stretching is even more pronounced when cells shape our organs at the embryo stage, and when they invade tissues through narrow pores during cancer metastasis – but how cells undergo such large deformations without breaking has remained a mystery until now.
This week, researchers at IBEC and the UPC report a new physical property of cells – which they’re calling active superelasticity – that may explain the unusual ability of cells to undergo extreme deformations.
The team, led by Marino Arroyo and Xavier Trepat (centre and right), developed a new approach to subject epithelial tissues – the thin cellular layers that cover internal and external surfaces of the body – to very large deformations, up to four times their original size. These cellular layers are fundamental to life, as they protect the body from radiation, pollutants and pathogens. They’re also responsible for gas exchange in the lungs, absorption of nutrients in the gut, and excretion of urine in the kidneys.
Is there chemo- and surgery-free cancer treatment in our future? Mechano·Control team of researchers are working to answer this question with a candidate solution against breast cancer.
Latest CORDIS news and events post highlights Mechano·Control objectives and its connection to the TALVIN project, focused on the seek for a pancreatic cancer drug.
CORDIS (Community Research and Development Information Service) is the European Commission’s primary public repository and portal to disseminate information on all EU-funded research projects and their results in the broadest sense.
These last weeks the group of Aránzazu del Campo at the Institute for New Materials (INM) in Saarbrücken has been host to another Mechano·Control member: Laura Faure, a postdoc from Pere Roca-Cusachs group at IBEC. Aleeza Farrukh, a Research Scientist at Dynamic Biomaterials group, has shared with Laura some advanced patterning techniques that she will implement in her assays. By combining single-cell traction force measurements and advanced patterning, researchers will try to decipher the role of cell-cell and cell-matrix forces during tumour growth and spreading.
In order to unravel the relationship between stiffness and tumour spreading, researchers need to look first at how cancer cells interact with their surrounding cells and tissue. With this idea in mind, IBEC and INM Mechano·Control members have joined efforts to merge their expertise into an advanced assay combining single-cell Traction Force Microscopy and 3D gel-patterning. “If we succeed, we will be able to quantify the impact of tissue stiffness on cell-cell and cell-matrix adhesions at the single-cell level”, Laura says. “To date, we don’t really know which forces trigger tumour spreading”, Aleeza adds. “This assay will help us understand the impact of rigidity changes in tumour growth and spreading in much more detail”. This is the third time that IBEC and INM teams meet to share skills and ideas within the project’s framework.
As part of Mechano·Control consortium strategy, partners have been sharing their know-how at all stages and scales of the project. Utrecht Research team has received several visits: from J Zanetta Zoi Kechagia, who spent 2 weeks working with organoids at their lab, to the visit of Noviocell sharing some samples with UMCU team. Also Johan De Rooij (UMCU) has been visiting del Campo (INM) in Saarbrücken and Mind the Byte has been working on its first drug candidate in tight interplay with De Rooij (UMCU) and Xavier Trepat (IBEC). Furthermore, Sergi Garcia-Manyes, head of Biological Physics & Soft Matter Group at King’s College London, has incorporated Amy Beedle, a postdoc holding a trans fellowship to visit several of the partners’ labs during her stay.
The next consortium meeting is to be celebrated in November the 16th, when all Mechano·Control partners will meet at Utrecht to discuss the project advances and the near future guidelines.